Landon Pediatric Foundation
12
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Evaluating Efficacy of Smart Device in Assisting With Inhaler Technique and Adherence
Role: lead
Diagnostic Breath Analysis for Detection of Ventilator Acquired Pneumonia (VAP)
Role: lead
Thora-3DI™ for Evaluation of Severity of Chronic Obstructive Pulmonary Disease (COPD)
Role: lead
Sepsis, Severe Sepsis and Septic Shock Detection by Breath Analysis
Role: lead
Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center
Role: lead
Home COPD and Open Ventilation Evaluation (HOPE) Study
Role: lead
Diagnostic Breath Analysis Study to Detect Sepsis
Role: lead
Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study
Role: lead
Volatile Organic Compounds in Cystic Fibrosis
Role: lead
Volatile Organic Compounds in Staphylococcus Aureus Patients
Role: lead
Home Sleep Testing in Neuromuscular Disease Patients
Role: lead
Tuberculosis Volatile Organic Compounds
Role: lead
All 12 trials loaded